GSK-GLP112755

Study Sponsor: GSK

Study Title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Pioglitazone With or Without Metformin in Subjects with Type 2 Diabetes Mellitus

Medicine or Vaccine (generic name)

albiglutide

Sponsor Identification Number

GLP112755

Trial Registry Identification Number(#'s)

NCT00849056 2008-007662-37

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=112755

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00849056

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2008-007662-37

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format

Date Added to this Site

May 2015